Additionally, miR-101 suppresses angiogenesis and metastasis of nasopharyngeal carcinoma cell through directly inhibiting ITGA3 [29], and miR-203 abolished cervical cancer angiogenesis and growth of the tumor by targeting VEGF-A [30]. This evidence concerns the gene ITGA3 and nasopharyngeal carcinoma.